RARustom Antia

Rustom Antia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rustom Antia has a total of 320 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of Dose on Norovirus Antibody Kinetics Following Infection or Vaccination

    by Murphy John, Yang Ge, W Zane Billings, Savannah L Miller, Cora Hirst, Rustom Antia, Katia Koelle, Ye Shen, Benjamin A Lopman, Robert L Atmar, et al.

    Background: Noroviruses are a leading cause of acute gastroenteritis worldwide, yet no licensed vaccines currently exist. Antibody-mediated immunity provides protection, but the relationship between norovirus exposure dose and antibody kinetics remains unclear. Methods: We analyzed longitudinal data on histo-blood group antigen–blocking, IgA, and IgG antibodies from a human norovirus infection trial and a candidate vaccine trial. We developed hierarchical nonlinear Bayesian models to characterize antibody kinetics following different amounts of virus or vaccine antigen exposure within infection and vaccination settings. We fit models with exponential and power-law decay terms and compared their performance. Results: Across studies and antibody types, the amount of antigen individuals were exposed to influenced early antibody kinetics, including growth, peak, and decay, but effects differed between infection and vaccination. Doses that produced larger initial antibody boosts also decayed faster, resulting in little association with 1-year antibody persistence. Conclusions: Our findings suggest that the amount and type of antigen exposure shape early antibody kinetics but not lasting durability. This reflects a trade-off between dose-induced initial immune boost and subsequent waning.

  • Open Access

    Upper respiratory tract CD8+ tissue-resident memory T cells protect against viral transmission

    by Sarah E. Michalets, Yixel Soto-Vazquez, Kathryn M. Moore, M. Elliott Williams, Ananya Saha, Ariana Jimenez, Yu-Shan Huang, Anice C. Lowen, Christopher D. Scharer, Alison Swaims-Kohlmeier, et al.

    Intranasal vaccination elicits CD8 tissue-resident memory T cells (TRM) throughout the respiratory tract that provide cross-protection against heterosubtypic viral strains and reduce immunopathology. We previously demonstrated that CD8 TRM can reduce the probability of respiratory virus transmission and the magnitude of infection, using a murine model of parainfluenza virus transmission. Here, we show that CD8 TRM-mediated protection occurs independently of circulating leukocytes, B cells, or CD4 T cells. Additionally, we investigate the contributions of CD8 TRM in different respiratory tract compartments and illustrate that CD8 TRM in the upper respiratory tract (URT), but not the lower respiratory tract (LRT), become activated and proliferate in response to transmitted virus. Furthermore, we demonstrate that CD8 TRM in the URT alone provide sufficient immune surveillance to prevent propagation of infection after viral transmission. These findings offer insights into the development of T cell–based respiratory virus vaccines and shed light on the critical role of URT CD8 TRM in the prevention of viral transmission.

  • Open Access

    CD8+ T cells and Humoral Immunity Influence the Development of Antibody-Dependent Enhancement: Implications for Vaccine Design

    by Riley S Drake, Hasan R Ahmed, Anmol Chandele, Rafi Ahmed, Kaja Murali-Krishna, Rustom Antia

    Dengue virus (DENV) infection is a major and growing global health threat. The development of a safe and effective vaccine regardless of prior dengue immunity remains an unmet need. Virus-specific antibodies typically limit viral replication. In contrast, low-to-intermediate dengue-specific antibody titers can enhance viral replication and increase disease severity—a phenomenon known as antibody-dependent enhancement (ADE). ADE complicates dengue vaccine development; signals of ADE were observed in the CYD-TDV (Dengvaxia) vaccine trials but have not yet been reported for trials of TAK-003 (Qdenga). To better understand how prior immunity influences dengue infection outcomes, we developed a mechanistic within-host model of acute dengue infection dynamics that incorporates both humoral immunity and CD8+ T cells. Model simulations predict that severe disease is most likely when dengue-specific antibody titers are intermediate and dengue-specific CD8+ T-cell immunity is low at the time of infection. In our simulations, increasing pre-infection levels of CD8+ T-cell immunity reduces disease severity in a dose-dependent manner and can mitigate ADE. Our results suggest a mechanistic interaction between antibody levels and CD8+ T-cell immunity that may influence whether enhanced viral replication leads to severe disease. The model provides a possible explanation for why ADE is frequently observed in infections of nonhuman primates following passive antibody transfer, yet is less common during secondary infections in humans with memory CD8+ T cells. These findings may help interpret differences in reported clinical outcomes of dengue vaccine trials and highlight the importance of considering CD8+ T-cell responses in the design of future dengue vaccines. Importance: Vaccines, including those against dengue viruses, are typically designed to elicit humoral (antibody-mediated) immunity, as antibody titers are commonly used as primary correlates of protection. Because CD8+ T-cell responses are not usually primary correlates and are more challenging to measure, they have received comparatively less attention. For viruses such as dengue, however, antibodies can exacerbate disease severity through antibody-dependent enhancement (ADE), underscoring the need to understand how humoral and cellular immunity interact. Here, we present a mechanistic model showing that severe dengue disease arises not only from low-to-intermediate antibody levels but also from insufficient CD8+ T-cell immunity at the time of infection. The model predicts that CD8+ T-cell responses can mitigate ADE-associated pathology and may help explain the differing levels of protection observed for CYD-TDV and TAK-003 vaccines. These findings suggest that evaluating CD8+ T-cell responses alongside antibody titers may be important for assessing vaccine safety and protection.

  • Open Access

    Preventing Disease Emergence Following Eradication: Application to Mpox

    by Cora Hirst, Julia Deichmann, Ananya Saha, Ira Longini, Andreas Handel, Marc Lipsitch, Daniel Weissman, Rustom Antia

    We use simple mathematical models to explore the factors that influence the evolutionary emergence of mpox to a pathogen capable of sustained human to human transmission that poses a global threat. Smallpox eradication followed by the discontinuation of immunization with vaccinia has led to a decline in the level of population immunity against related poxviruses such as mpox. This decline in immunity results in an increase in both the number of spillovers and the extent of human to human transmission. We find that increases in transmissibility of mpox between humans have a much greater effect on the probability of evolutionary emergence compared with increases in the number of zoonotic spillovers. We suggest that while mpox only needs to have a reproductive number slightly greater than one to become endemic, subsequent adaptation is likely to further increase its transmissibility in the human population. As a consequence a much higher level of vaccination (or other intervention) is needed to control the pathogen after its evolutionary emergence compared with what is needed to prevent it from emerging in the first place.

  • Open Access

    Density dependence affects population recovery following an epidemic

    by Rustom Antia, Bert Baumgaertner, James J Bull

    Current epidemiological models for the regulation of host populations by pathogens suggest that the reduction in the host population is largest shortly after the epidemic phase and that the host population partly recovers in the subsequent approach to endemicity. We find that this conventional view is not robust to a simple, biologically motivated addition: density-dependent population regulation (homeostasis). While rapid homeostasis typically enables a population rebound after the initial population suppression (the conventional view), but weak homeostasis results in the opposite --- greater population suppression during the endemic phase compared to the initial epidemic. The effect of homeostasis can be substantial. This finding complicates the prediction of long term outcomes of population suppression by pathogens but not of short term outcomes.

  • Quantifying the waning of humoral immunity

    by Ananya Saha, Hasan Ahmed, Cora Hirst, Katia Koelle, Andreas Handel, Peter Teunis, Rustom Antia


  • Open Access

    Cumulants, Moments and Selection: The Connection Between Evolution and Statistics

    by Hasan Ahmed, Deena Goodgold, Khushali Kothari, Rustom Antia

    Cumulants and moments are closely related to the basic mathematics of continuous and discrete selection (respectively). These relationships generalize Fisher's fundamental theorem of natural selection and also make clear some of its limitation. The relationship between cumulants and continuous selection is especially intuitive and also provides an alternative way to understand cumulants. We show that a similarly simple relationship exists between moments and discrete selection. In more complex scenarios, we show that thinking of selection over discrete generations has significant advantages. For a simple mutation model, we find exact solutions for the equilibrium moments of the fitness distribution. These solutions are surprisingly simple and have some interesting implications including: a necessary and sufficient condition for mutation selection balance, a very simple formula for mean fitness and the fact that the shape of the equilibrium fitness distribution is determined solely by mutation (whereas the scale is determined by the starting fitness distribution).

  • Open Access

    Influenza vaccine based on AS03-adjuvanted chimeric HA induces long-lived stalk-specific plasma cells in bone marrow and lymph nodes of nonhuman primates

    by Akil Akhtar, Tiffany M. Styles, Chunyang Gu, André Nicolás León, Gregory K. Tharp, Kasey Stokdyk, Anass Abbad, Cora Hirst, Shirin Strohmeier, Gabriele Neumann, et al.

    Current influenza vaccines face challenges due to antigenic evolution of the circulating virus and waning immunity in humans. Here we investigated the durability of humoral immunity induced by an influenza vaccine based on AS03-adjuvanted chimeric hemagglutinin (cHA) in nonhuman primates (NHPs). Two groups of NHPs received two doses of a seasonal quadrivalent influenza vaccine, followed by sequential immunization with split virus cHA vaccines cH8/1N1, and cH5/1N1. One group received cHA immunizations with AS03 adjuvant. We monitored serum antibodies and long-lived plasma cells in bone marrow for nearly 2 years after the final vaccination. cHA vaccines induced stalk-specific antibody responses. The addition of AS03 enhanced both the magnitude and durability of humoral immunity by establishing long-lived plasma cells in the bone marrow and lymph nodes for nearly 2 years. Passive transfer of NHP serum provided protection against challenge with heterologous influenza A virus strains in mice. This study highlights the potential of the AS03-adjuvanted chimeric HA vaccine strategy to provide durable and broadly protective humoral immunity.


  • Open Access

    Maternal antibodies and density dependence affect suppression of host populations by novel pathogens

    by James J Bull, Rustom Antia

    Current theory for the regulation of host populations by pathogens suggests that a high level of suppression during the initial epidemic phase will be followed by a population rebound with decreased virulence due to pathogen and host evolution, and the extent of host suppression increases with increasing pathogen transmissibility ( R 0 ) and virulence. Using simple epidemiological models, we explore the effect of two factors on short- and long-term suppression: the strength of density-dependent population regulation (homeostasis) and maternal antibodies. We showed previously that, in the absence of maternal antibodies, the strength of homeostasis can greatly effect long term population suppression. Here we find that maternal antibodies can significantly reduce suppression of the host population if they attenuate rather than block infections, but then only for rapid homeostasis. A higher R 0 can result in lower suppression, and the average virulence can decline over time without any (genetic) evolution. Our results suggest the need for a nuanced view of long-term suppression by a new pathogen, with the outcome sensitive to many details even in the absence of evolution.

  • Open Access

    Quantifying the waning of humoral immunity

    by Ananya Saha, Hasan Ahmed, Cora Hirst, Katia Koelle, Andreas Handel, Peter Teunis, Rustom Antia

    Immunological memory is a defining feature of immunity, yet surprisingly there is no consensus on how to quantitatively describe how antibody titers wane over time. A major problem is that the slow waning of antibody titers requires the collection of data for decades post-infection or vaccination. Our analysis of the largest existing dataset shows that a power-law model describes antibody waning better than other frequently used models. Our analysis suggests: (i) Protective levels of antibodies to many vaccine/virus antigens may be maintained for longer than previously estimated. (ii) The rate of waning of antibodies to protein toxoid vaccines such as tetanus may be similar to those elicited by live virus infections. (iii) The long-term waning of antibodies can be estimated from data for a much shorter time-frame of about 1-3 years following immunization, suggesting that using a power-law analysis could allow rapid estimation for the waning of immunity to new vaccines.